Literature DB >> 19691523

Multiple viral infections post-hematopoietic stem cell transplantation are linked to the appearance of chronic GVHD among pediatric recipients of allogeneic grafts.

Helena A Olkinuora1, Mervi H Taskinen, Ulla M Saarinen-Pihkala, Kim K Vettenranta.   

Abstract

Delayed immune reconstitution and the ensuing opportunistic infections among children following hematopoietic stem cell transplantation (HSCT) are associated with increased treatment-related morbidity and mortality (TRM). We retrospectively evaluated the impact of viral infections on the posttransplant recovery of pediatric recipients of stem cell grafts as a reflection of their posttransplant immunoreconstitution in a single institution setting. The case histories of 124 children (during 1/1999-9/2006) were reviewed for infectious episodes, and correlated with their respective clinical parameters. Patients with a high risk for CMV received prophylaxis, but failures in the prophylaxis were common (40%). 110/124 (89%) of these allogeneic patients had at least one viral reactivation/clinical infection posttransplant. In this group of pediatric patients chronic GVHD (P<0.001) and secondary graft failure were significantly (P=0.001) associated with early (during the first 100 days post HSCT), multiple (> or = 2) viral infections. Our data indicate that viruses are common pathogens among pediatric recipients of allogeneic stem cell grafts. In this group of patients multiple viral infections early on seem to reflect an even more severe degree of immunological derangement in the recipient and identify a group of patients with an increased risk of chronic GVHD and secondary graft failure.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19691523     DOI: 10.1111/j.1399-3046.2009.01226.x

Source DB:  PubMed          Journal:  Pediatr Transplant        ISSN: 1397-3142


  7 in total

1.  The cumulative burden of double-stranded DNA virus detection after allogeneic HCT is associated with increased mortality.

Authors:  Joshua A Hill; Bryan T Mayer; Hu Xie; Wendy M Leisenring; Meei-Li Huang; Terry Stevens-Ayers; Filippo Milano; Colleen Delaney; Mohamed L Sorror; Brenda M Sandmaier; Garrett Nichols; Danielle M Zerr; Keith R Jerome; Joshua T Schiffer; Michael Boeckh
Journal:  Blood       Date:  2017-02-16       Impact factor: 22.113

2.  Invasive fungal disease is associated with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplant: a single center, retrospective study.

Authors:  Hua Jin; Zhiping Fan; Fen Huang; Yanyan Chai; Li Xuan; Ren Lin; Na Xu; Jieyu Ye; Jing Sun; Qifa Liu
Journal:  Infection       Date:  2019-02-07       Impact factor: 3.553

3.  Risk Factors and Utility of a Risk-Based Algorithm for Monitoring Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections in Pediatric Recipients after Allogeneic Hematopoietic Cell Transplantation.

Authors:  Evelyn Rustia; Leah Violago; Zhezhen Jin; Marc D Foca; Justine M Kahn; Staci Arnold; Jean Sosna; Monica Bhatia; Andrew L Kung; Diane George; James H Garvin; Prakash Satwani
Journal:  Biol Blood Marrow Transplant       Date:  2016-05-29       Impact factor: 5.742

4.  Sequential anti-cytomegalovirus response monitoring may allow prediction of cytomegalovirus reactivation after allogeneic stem cell transplantation.

Authors:  Sylvia Borchers; Melanie Bremm; Thomas Lehrnbecher; Elke Dammann; Brigitte Pabst; Benno Wölk; Ruth Esser; Meral Yildiz; Matthias Eder; Michael Stadler; Peter Bader; Hans Martin; Andrea Jarisch; Gisbert Schneider; Thomas Klingebiel; Arnold Ganser; Eva M Weissinger; Ulrike Koehl
Journal:  PLoS One       Date:  2012-12-13       Impact factor: 3.240

5.  A combined biomarker and clinical panel for chronic graft versus host disease diagnosis.

Authors:  Joseph Pidala; Tara K Sigdel; Anyou Wang; Sue Hsieh; Yoshi Inamoto; Paul J Martin; Mary Ed Flowers; John A Hansen; Stephanie J Lee; Minnie M Sarwal
Journal:  J Pathol Clin Res       Date:  2016-11-29

6.  Viral reactivations following hematopoietic stem cell transplantation in pediatric patients - A single center 11-year analysis.

Authors:  Franziska Düver; Benedikt Weißbrich; Matthias Eyrich; Matthias Wölfl; Paul G Schlegel; Verena Wiegering
Journal:  PLoS One       Date:  2020-02-04       Impact factor: 3.240

7.  Association between Antiviral Prophylaxis and Cytomegalovirus and Epstein-Barr Virus DNAemia in Pediatric Recipients of Allogeneic Hematopoietic Stem Cell Transplant.

Authors:  Ndeye Soukeyna Diop; Pascal Roland Enok Bonong; Chantal Buteau; Michel Duval; Jacques Lacroix; Louise Laporte; Marisa Tucci; Nancy Robitaille; Philip C Spinella; Geoffrey Cuvelier; Suzanne M Vercauteren; Victor Lewis; Caroline Alfieri; Helen Trottier
Journal:  Vaccines (Basel)       Date:  2021-06-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.